Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMar 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 15, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 13, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 8, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 8, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 8, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 2, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 2, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2017View HTMLDownload DOCDownload PDF
10-KAnnual report which provides a comprehensive overview of the company for the past yearFeb 27, 2017View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventFeb 23, 2017View HTMLDownload DOCDownload PDFDownload XLS
5Annual filing director officer or owner of more than ten percent.Feb 14, 2017View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2017View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-132

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information